ESC 365 - Lessons from REDUCE-IT: How will the results impact practice?

Open Access

Lessons from REDUCE-IT: How will the results impact practice?

Session: Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides

Topic: Lipid-Lowering Agents

Speaker: Professor D. Bhatt (New York City, US)

Organised by PACE-CME, supported by Amarin in the form of an educational grant

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Deepak Bhatt

Mount Sinai Hospital, New York City (United States of America)

36 presentations

4 followers

4 more presentations in this session

Introduction.

Speaker: Professor P. Libby (Boston, US)

The residual risk challenge in CVD: How important are triglycerides?

Speaker: Professor U. Landmesser (Berlin, DE)

Non-LDL in CV risk management & guidelines: What are the opportunities?

Speaker: Professor K. Ray (London, GB)

Discussion.

Speaker: Professor P. Libby (Boston, US)

Access the full session

Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides

Speakers: Professor D. Bhatt, Professor P. Libby, Professor U. Landmesser, Professor K. Ray, Professor P. Libby

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Related content

Open Access

Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

27 August 2021

Open Access

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

27 August 2021

ESC Premium Access

Triglycerides: the underestimated player.

27 August 2021

ESC 365 is supported by